✦ LIBER ✦

Rotigotine transdermal patch: a guide to its use in Parkinson’s disease and restless leg syndrome

✍ Scribed by Lyseng-Williamson, Katherine A.; Sanford, Mark; Scott, Lesley J.

Book ID: 121439522
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Tongue: English
Weight: 269 KB
Volume: 29
Category: Article
ISSN: 1172-0360
DOI: 10.1007/s40267-013-0016-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rotigotine: Transdermal Dopamine Agonist

Rotigotine: Transdermal Dopamine Agonist Treatment of Parkinson's Disease and Restless Legs Syndrome

✍ Splinter, M. Y 📂 Article 📅 2007 🏛 Harvey Whitney Books Company 🌐 English ⚖ 232 KB

Rotigotine transdermal patch in moderate

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study

✍ Wolfgang H. Oertel; Heike Beneš; Diego Garcia-Borreguero; Birgit Högl; Werner Po 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 363 KB

One year open-label safety and efficacy

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

✍ Wolfgang H. Oertel; Heike Benes; Diego Garcia-Borreguero; Peter Geisler; Birgit 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Effectiveness and tolerability of rotigo

Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany

✍ Stiasny-Kolster, Karin; Berg, Daniela; Hofmann, Werner E.; Berkels, Reinhard; Gr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Long-term safety and efficacy of rotigot

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

✍ Wolfgang Oertel; Claudia Trenkwalder; Heike Beneš; Luigi Ferini-Strambi; Birgit 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 391 KB

Rotigotine transdermal patch in early Pa

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

✍ Nir Giladi; Babak Boroojerdi; Amos D. Korczyn; David J. Burn; Carl E. Clarke; An 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract Rotigotine is a new, non‐ergot dopamine agonist formulated in a transdermal delivery system. The present study was to investigate the efficacy and safety of the rotigotine transdermal patch in the treatment of early Parkinson's disease. Patients (n = 561) were randomized to rotigotine,